D-0099-2018 Class II Terminated

Recalled by Hetero Labs, Ltd. - Unit III — Hyderabad, N/A

FDA drug recall D-0099-2018 was initiated by Hetero Labs, Ltd. - Unit III on Oct 12, 2017 and is designated Class II. Reason for recall: Presence of foreign substance (screw) The recall status is terminated (terminated Sep 3, 2020). Affected quantity: 4050 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 6, 2017
Initiation Date
Oct 12, 2017
Termination Date
Sep 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4050 bottles

Product description

Levetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Jeedimetla,Hyderabad - 500 055, India, NDC 31722-574-47

Reason for recall

Presence of foreign substance (screw)

Distribution pattern

NJ

Code information

Lot # E170346, Exp 02/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0099-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0099-2018. Report a data issue: hello@regdatalab.com.